MDxHealth
MDXH
4 hedge funds and large institutions have $13.8M invested in MDxHealth in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.59% less ownership
Funds ownership: 1.9% → 1.31% (-0.59%)
20% less funds holding
Funds holding: 5 → 4 (-1)
44% less capital invested
Capital invested by funds: $24.7M → $13.8M (-$10.9M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$15 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MPU
MVM Partners (UK)
London,
United Kingdom
|
-$7.56M |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$43.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BL
1
Bleichroeder LP
New York
| $13.2M | – | – | – |
|
|
PCM
2
Perkins Capital Management
Wayzata,
Minnesota
| $572K | -$43.2K | -5,650 | -6% |
|
|
3
UBS Group
Zurich,
Switzerland
| $15K | +$15 | +2 | +0.1% |
|
|
MPU
4
MVM Partners (UK)
London,
United Kingdom
| – | -$7.56M | -916,666 | Closed |
|
MDXH Hedge Fund Activity: Q3 2022 in Review
4 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in MDxHealth (MDXH) for Q3 2022, worth a combined $13.8M — down 44% from $24.7M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MDXH and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $15. The largest seller was MVM Partners (UK), exiting entirely with an estimated $7.56M sold.
- 4 institutional investors held MDxHealth (MDXH) as of Q3 2022, down from 5 in Q2 2022.
- Funds reported $13.8M of MDxHealth stock for Q3 2022, down 44% quarter-over-quarter.
- 0 funds opened new MDxHealth positions in Q3 2022 and 1 closed out, a net change of -1 holder.
- The largest MDxHealth buyer in Q3 2022 was UBS Group, an estimated $15 added.
- The largest MDxHealth seller in Q3 2022 was MVM Partners (UK), an estimated $7.56M sold.
Based on aggregated 13F filings for Q3 2022.